Censo Biotechnologies Ltd
Roslin Biocentre
Wallace Building
Roslin
Midlothian
EH25 9PP
Tel: 44-131-440-6541
Website: http://www.censobio.com/
Email: enquiries@censobio.com
About Censo Biotechnologies Ltd
Censo Biotechnologies Ltd is a stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking. The company has the capabilities to generate induced pluripotent stem cells (iPSCs) from large cohorts of individuals and use the potential of these cells to create virtually any cell in the human body. By developing cell-based models of disease using cells from a diverse range of tissue donors, the company supports the development of new, targeted treatments for disease. Its major focus is the generation of novel data on drug efficacy and drug response variation for a given population. The company was founded in 2016 through the merger of Roslin Cellab and Roslin Cell Sciences and has facilities in both Edinburgh and Cambridge, UK.YEAR FOUNDED:
2016
LEADERSHIP:
CEO: Aidan Courtney
FOLLOW CENSOR BIOTECHNOLOGIES:
Tweets by Censo Biotechnologies
4 articles about Censo Biotechnologies Ltd
-
Axol Bioscience and Censo Biotechnologies Announce Merger
3/17/2021
Merger accompanied by £3.8million ($5.3m USD) investment across shareholders, which will be used to fund recruitment and growth of the business
-
Evotec AG Expands iPSC Drug Discovery Leadership Through Strategic Collaboration With Censo Biotechnologies
6/28/2017
-
Cellectricon And Censo Biotechnologies Introduce A Joint Technology Access Program Utilizing High-Quality Human Ipsc-Based Discovery Services For CNS And Pain Research
1/26/2017
-
Cellectricon And Censo Biotechnologies Collaborate To Offer High-Quality Human Ipsc-Based Discovery Services For CNS And Pain Research
9/8/2016